Evaluation the effect of allium hirtifolium in the treatment of hyperlipidemia

Phase 3

• Conditions: Hyperlipidemia.; Hyperlipidemia, unspecified; E78.5

• Registration Number: IRCT20150721023282N7
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age of more than 18 years
Serum level of LDL between 100 to 160 mg/dL
Having less than 2 cardiovascular risk factors

Exclusion Criteria

Cardiac stable angina
Diabetes mellitus
Diseases affecting level of serum lipids
Use of drugs affecting level of serum lipids

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum level of triglycerides. Timepoint: Before the intervention and the end of intervention (6 weeks after the start of intervention). Method of measurement: Blood test.;Serum level of LDL. Timepoint: Before the intervention and the end of intervention (6 weeks after the start of intervention). Method of measurement: Blood test.;Serum level of HDL. Timepoint: Before the intervention and the end of intervention (6 weeks after the start of intervention). Method of measurement: Blood test.;Serum level of total cholesterol. Timepoint: Before the intervention and the end of intervention (6 weeks after the start of intervention). Method of measurement: Blood test.